Enhabit, Inc. (NYSE:EHAB) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Enhabit, Inc. (NYSE:EHAB) have received a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $12.10.

Several analysts have commented on EHAB shares. Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Truist Financial set a $10.50 price target on shares of Enhabit and gave the stock a “hold” rating in a report on Wednesday, January 7th. Oppenheimer upgraded Enhabit from a “market perform” rating to an “outperform” rating and set a $14.00 price objective for the company in a report on Thursday, January 22nd. Finally, Citigroup reissued a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th.

Enhabit Trading Up 1.1%

Shares of NYSE:EHAB opened at $11.15 on Friday. The company has a market capitalization of $564.05 million, a PE ratio of -44.58 and a beta of 1.66. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.75. Enhabit has a 12-month low of $6.47 and a 12-month high of $11.35. The business’s fifty day simple moving average is $9.99 and its 200-day simple moving average is $8.63.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The firm had revenue of $263.60 million during the quarter, compared to analysts’ expectations of $267.08 million. As a group, equities research analysts predict that Enhabit will post 0.22 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Enhabit

Several hedge funds have recently modified their holdings of EHAB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Enhabit by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock worth $262,000 after purchasing an additional 1,248 shares in the last quarter. Orion Porfolio Solutions LLC raised its holdings in shares of Enhabit by 1.0% in the third quarter. Orion Porfolio Solutions LLC now owns 144,016 shares of the company’s stock worth $1,154,000 after buying an additional 1,361 shares during the last quarter. Strs Ohio lifted its stake in shares of Enhabit by 10.9% during the third quarter. Strs Ohio now owns 15,300 shares of the company’s stock worth $123,000 after buying an additional 1,500 shares during the period. Osaic Holdings Inc. grew its holdings in shares of Enhabit by 337.5% during the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after buying an additional 2,018 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Enhabit by 82.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after acquiring an additional 2,059 shares during the period.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.